- Nachrichtendetail
-
11.03.2024 12:15:37 - dpa-AFX: *REGENERON PHARMA: FDA APPROVES PRALUENT INJECTION TO TREAT CHILDREN WITH GENETIC FORM OF HIGH CHOLESTEROL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 898,400 | 31.05.24 08:14:27 | +17,200 | +1,95% | 883,600 | 894,400 | 898,400 | 881,200 |
